tetano
Editor, Senior Moderator
J Investig Allergol Clin Immunol. 2020 May 14:0. doi: 10.18176/jiaci.0567. [Epub ahead of print]
Olfactory dysfunction in the COVID-19 outbreak.
Izquierdo-Dominguez A[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Rojas-Lechuga MJ[SUP]4,[/SUP][SUP]5,[/SUP][SUP]6[/SUP], Mullol J[SUP]4,[/SUP][SUP]5,[/SUP][SUP]6[/SUP], Alobid I[SUP]2,[/SUP][SUP]4,[/SUP][SUP]5,[/SUP][SUP]6[/SUP].
Author information
Abstract
The first cases of coronavirus 2019 (COVID-19) occurred in Wuhan, China, and rapidly become a public health emergency of international proportions. The disease may cause mild-to-severe acute respiratory syndrome (SARS) and is caused by a SARS-CoV-2 coronavirus infection. The clinical manifestations of COVID-19 include fever, dry cough, fatigue, sputum production, shortness of breath, sore throat, and headache. This article is a narrative review with the aim of analyzing the current literature on postviral olfactory dysfunction (OD) related to SARS-CoV-2 pandemics. Since the initial anecdotal reports from China, international reports on COVID-19 patients have been increasing, describing a 5% to 85% range of loss of smell. To date, the literature is widely heterogeneous regarding the loss of smell; therefore, we advise home isolation measures and/or social distancing, and to carry out diagnostic tests for SARS-CoV-2 when possible in those patients with sudden and severe loss of smell who cannot be promptly evaluated.
KEYWORDS:
Anosmia; COVID-19; Coronavirus; SARS-CoV-2.; Smell loss; Taste disorder
PMID:32406374DOI:10.18176/jiaci.0567
Olfactory dysfunction in the COVID-19 outbreak.
Izquierdo-Dominguez A[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Rojas-Lechuga MJ[SUP]4,[/SUP][SUP]5,[/SUP][SUP]6[/SUP], Mullol J[SUP]4,[/SUP][SUP]5,[/SUP][SUP]6[/SUP], Alobid I[SUP]2,[/SUP][SUP]4,[/SUP][SUP]5,[/SUP][SUP]6[/SUP].
Author information
Abstract
The first cases of coronavirus 2019 (COVID-19) occurred in Wuhan, China, and rapidly become a public health emergency of international proportions. The disease may cause mild-to-severe acute respiratory syndrome (SARS) and is caused by a SARS-CoV-2 coronavirus infection. The clinical manifestations of COVID-19 include fever, dry cough, fatigue, sputum production, shortness of breath, sore throat, and headache. This article is a narrative review with the aim of analyzing the current literature on postviral olfactory dysfunction (OD) related to SARS-CoV-2 pandemics. Since the initial anecdotal reports from China, international reports on COVID-19 patients have been increasing, describing a 5% to 85% range of loss of smell. To date, the literature is widely heterogeneous regarding the loss of smell; therefore, we advise home isolation measures and/or social distancing, and to carry out diagnostic tests for SARS-CoV-2 when possible in those patients with sudden and severe loss of smell who cannot be promptly evaluated.
KEYWORDS:
Anosmia; COVID-19; Coronavirus; SARS-CoV-2.; Smell loss; Taste disorder
PMID:32406374DOI:10.18176/jiaci.0567